Using and interpreting cost-effectiveness acceptability curves: an example using data from a trial of management strategies for atrial fibrillation
暂无分享,去创建一个
Elisabeth Fenwick | Graham Nichol | Adrian R Levy | A. Levy | G. Nichol | E. Fenwick | D. Marshall | Deborah A Marshall
[1] A Briggs,et al. Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane. , 1998, Health economics.
[2] M Gent,et al. Effect of Clinical Risk Stratification on Cost-Effectiveness of the Implantable Cardioverter-Defibrillator: The Canadian Implantable Defibrillator Study , 2001, Circulation.
[3] P. Bower,et al. Meta-analysis of data on costs from trials of counselling in primary care: using individual patient data to overcome sample size limitations in economic analyses , 2003, BMJ : British Medical Journal.
[4] M. Sculpher,et al. Representing uncertainty: the role of cost-effectiveness acceptability curves. , 2001, Health economics.
[5] W C Black,et al. The CE Plane , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.
[6] Andrew Briggs,et al. Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions. , 2004, Health economics.
[7] M J Al,et al. Costs, effects and C/E-ratios alongside a clinical trial. , 1994, Health economics.
[8] Anthony O'Hagan,et al. Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis. , 2003, BMJ : British Medical Journal.
[9] A. Eden,et al. Cost-Effectiveness of Lung-Volume-Reduction Surgery for Patients With Severe Emphysema , 2004 .
[10] O C Ukoumunne,et al. Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach , 2003, Psychological Medicine.
[11] A J Moskowitz,et al. Problems with Interval Estimates of the Incremental Cost—Effectiveness Ratio , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.
[12] Cam Donaldson,et al. An economic evaluation of activated protein C treatment for severe sepsis. , 2002, The New England journal of medicine.
[13] B J O'Brien,et al. Analysis of uncertainty in health care cost-effectiveness studies: an introduction to statistical issues and methods , 2002, Statistical methods in medical research.
[14] N. Zethraeus,et al. Definition, interpretation and calculation of cost-effectiveness acceptability curves. , 2000, Health economics.
[15] A L Waldo,et al. A comparison of rate control and rhythm control in patients with atrial fibrillation. , 2002, The New England journal of medicine.
[16] B. Delaney,et al. Cost effectiveness of initial endoscopy for dyspepsia in patients over age 50 years: a randomised controlled trial in primary care , 2000, The Lancet.
[17] A R Willan,et al. Confidence intervals for cost-effectiveness ratios: an application of Fieller's theorem. , 1996, Health economics.
[18] B. O'brien,et al. Cost-Effectiveness of Rhythm versus Rate Control in Atrial Fibrillation , 2004, Annals of Internal Medicine.
[19] Philip D. Harvey,et al. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40 , 1998, BMJ.
[20] A. Grant,et al. To Be or Not To Be in Normal Sinus Rhythm: What Do We Really Know? , 2004, Annals of Internal Medicine.
[21] M. Drummond,et al. An economic evaluation of sequential i.v./po moxifloxacin therapy compared to i.v./po co-amoxiclav with or without clarithromycin in the treatment of community-acquired pneumonia. , 2003, Chest.
[22] John Mullahy,et al. Net Health Benefits: A New Framework for the Analysis of Uncertainty in Cost-Effectiveness Analysis , 1998 .
[23] A H Briggs,et al. Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation. , 1997, Health economics.
[24] Paul Fenn,et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41) , 2000, BMJ : British Medical Journal.
[25] A H Briggs,et al. Handling uncertainty when performing economic evaluation of healthcare interventions. , 1999, Health technology assessment.
[26] A A Stinnett,et al. Net Health Benefits , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.